Compare RAPP & MFA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RAPP | MFA |
|---|---|---|
| Founded | 2022 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Real Estate Investment Trusts |
| Sector | | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 976.0M |
| IPO Year | 2024 | N/A |
| Metric | RAPP | MFA |
|---|---|---|
| Price | $26.92 | $10.10 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 7 |
| Target Price | ★ $47.80 | $10.96 |
| AVG Volume (30 Days) | 427.2K | ★ 1.4M |
| Earning Date | 11-06-2025 | 02-18-2026 |
| Dividend Yield | N/A | ★ 14.53% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.86 |
| Revenue | N/A | ★ $279,011,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $3.18 |
| P/E Ratio | ★ N/A | $11.53 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $6.43 | $7.85 |
| 52 Week High | $42.27 | $11.08 |
| Indicator | RAPP | MFA |
|---|---|---|
| Relative Strength Index (RSI) | 42.60 | 67.77 |
| Support Level | $26.30 | $9.59 |
| Resistance Level | $28.10 | $9.78 |
| Average True Range (ATR) | 1.80 | 0.20 |
| MACD | -0.37 | 0.04 |
| Stochastic Oscillator | 20.07 | 98.24 |
Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.
MFA Financial Inc is a specialty finance company that invests in and finances residential mortgage assets. Its principal business objective is to deliver shareholder value through the generation of distributable income and through asset performance linked to residential mortgage credit fundamentals. The company selectively invests in residential mortgage assets with a focus on credit analysis, projected prepayment rates, interest rate sensitivity and expected return. The company's reportable segments include mortgage-related assets and Lima One.